We aim to provide results that can be translated into diagnostics, treatments or therapies that reduce global health burdens We aim to use the most appropriate technology to provide the data to solve important questions in biomedicine Our passion for discovery drives our quest to uncover the basis of genetic and infectious disease Our achievements and contributions in genetics place the Sanger Institute at the forefront of the field One of the first outputs of our sequencing work was the collaboration that led to the discovery of the BRCA2 breast cancer gene